Another hurdle to the clinical application may be significant costs due to measurement of biomarkers.
← all excerpts
Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.
1
—
—
Another hurdle to the clinical application may be significant costs due to measurement of biomarkers.